Search Results
Found 1 results
510(k) Data Aggregation
(20 days)
The HORIZON 9000 WS (Cathlab) is a state-of-the-art computerized laboratory, capable of acquiring and displaying essential patient data such as ECG/Heart Rate, invasive blood pressure, pulse oximetry, respiration, cardiac output and body temperature. Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats.
The Cathlab is capable of acquiring and displaying essential patient data such as ECG/Heart Rate, invasive blood pressure, pulse oximetry, respiration, cardiac output and body temperature. Heart rate, multi-lead ECG and BP waveforms from different heart sites are continuously presented on the Physiological Waveform Display. The hemodynamic data, waveform and numerical, can be stored, recorded, analyzed and presented in a variety of report formats. The Cathlab runs on a UNIX/Sun Solaris* operating system on a SUN® computer that utilizes spowerful, real-time software to control the system operation and to process the vital patient sign data measurements acquired from the Physiological Front End or entered manually at the keyboard. The Thermal Array Chart Recorder provides a continuous recording of all monitored vital signs, patient ID, time and date during the procedures. A Laser Printer is provided in addition to the Chart Recorder in the central console. This provides printouts of textual and graphical summaries of all patient data and catheterization procedures.
This document describes a Special 510(k) for a device modification of the Horizon 9000WS Cathlab, specifically replacing the Patient Front End (PFE) with a Cathlab Front End (CFE). The submission aims to demonstrate that the modified device is substantially equivalent to the predicate device.
Here's an analysis of the provided text, focusing on acceptance criteria and supporting studies:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria are not explicitly stated as "acceptance criteria" but are embedded within the product specifications for the Cathlab Front End (CFE). The device performance is reported as meeting these specifications.
| Parameter | Acceptance Criteria (CFE Specification) | Reported Device Performance |
|---|---|---|
| Input Circuit Parameters | ||
| Chassis Leakage Current | < 50 µA, Meets or exceeds ANSI standard: "Safe Current Limits for Electromedical Apparatus," (SCLE) Dec, 1978 item 2.1.1. | < 50 µA, Meets or exceeds ANSI standard: "Safe Current Limits for Electromedical Apparatus," (SCLE) Dec, 1978 item 2.1.1. |
| ECG | ||
| Frequency Response (Monitor) | 0.5 to 40 Hz | 0.5 to 40 Hz |
| Frequency Response (Diagnostic) | 0.05 to 150 Hz, -3 dB | 0.05 to 150 Hz, -3 dB |
| Frequency Response (Exercise) | 1 to 25 Hz, -3 dB | 1 to 25 Hz, -3 dB |
| Input Impedance | Typical 20 MΩ; Min > 5 MΩ differential (DC to 10 Hz); 2.5 MΩ differential (10 to 100 Hz); 3 MΩ differential (at 10 Hz) | Typical 20 MΩ; Min > 5 MΩ differential (DC to 10 Hz); 2.5 MΩ differential (10 to 100 Hz); 3 MΩ differential (at 10 Hz) |
| Common Mode Rejection | At least 100 dB at 50/60 Hz (Without lead misbalance); 86 dB (with lead misbalance); In accordance with ANSI/AAMI EC11 (9) Para. 3.2.14. | At least 100 dB at 50/60 Hz (Without lead misbalance); 86 dB (with lead misbalance); In accordance with ANSI/AAMI EC11 (9) Para. 3.2.14. |
| Input Dynamic Range | ±5mV p-p at a rate up to 320mV/sec, as per ANSI/AAMI EC13(8) Para. 3.2.9.1. | ±5mV p-p at a rate up to 320mV/sec, as per ANSI/AAMI EC13(8) Para. 3.2.9.1. |
| Input Offset | ± 300mV, as per ANSI/AAMI EC13 Para. 3.2.9.1. | ± 300mV, as per ANSI/AAMI EC13 Para. 3.2.9.1. |
| Noise | Less than 30 μ V p-p referenced to input | Less than 30 μ V p-p referenced to input |
| Pacemaker Pulse Rejection | Reject pulses from 2.0 mV to 700 mV with 0.2 to 2.0 mSec pulse widths and ≥3.0mV for 0.1mSec pulse width | Reject pulses from 2.0 mV to 700 mV with 0.2 to 2.0 mSec pulse widths and ≥3.0mV for 0.1mSec pulse width |
| Defibrillator Protection | Up to 5 KV. Amplifier Recovery time: < 3 seconds | Up to 5 KV. Amplifier Recovery time: < 3 seconds |
| QRS Detection | 0.25 to 5.0 mV, 70-120 msec width | 0.25 to 5.0 mV, 70-120 msec width |
| Synchronous Defibrillation Signal | Pulse Width: 100 ms; Amplitude: 5 Vdc into 500Ω, short-circuit proof | Pulse Width: 100 ms; Amplitude: 5 Vdc into 500Ω, short-circuit proof |
| ECG Analog Output | 1 Volt / mVolt | 1 Volt / mVolt |
| Heart Rate | ||
| Range | 20 to 350 bpm | 20 to 350 bpm |
| Accuracy | Within 2 bpm | Within 2 bpm |
| Response Time | Less than 7 sec for step change of 60 bpm from a base of 60 bpm | Less than 7 sec for step change of 60 bpm from a base of 60 bpm |
| Blood Pressure | ||
| Input Sensitivity | 5 μvolts/volt/mmHg | 5 μvolts/volt/mmHg |
| Transducer Excitation | 5 Volt | 5 Volt |
| Ranges | -50 to +300 mmHg | -50 to +300 mmHg |
| Max Variation during Zero | ± 2 mmHg | ± 2 mmHg |
| Zero Accuracy | ± 0.2 mmHg | ± 0.2 mmHg |
| Zero Drift | Less than +/- 0.2 mmHg in 24 hours | Less than +/- 0.2 mmHg in 24 hours |
| Transducer Load Impedance | 300 – 600Ω | 300 – 600Ω |
| Linearity | Better than 1% of full scale | Better than 1% of full scale |
| Common Mode Rejection | 80 dB minimum (reference to chassis 50/60Hz) | 80 dB minimum (reference to chassis 50/60Hz) |
| Frequency Response | DC to 12 Hz (DC to 40 Hz optional) | DC to 12 Hz (DC to 40 Hz optional) |
| Cardiac Output | ||
| Range | 0.5 to 20 liter/minute | 0.5 to 20 liter/minute |
| Frequency Response | DC to 15 Hz | DC to 15 Hz |
| Blood Temperature Range | 27 °C to 45°C | 27 °C to 45°C |
| Injectate Temperature Range | 0°C to 25°C. (32°F to 77°F) | 0°C to 25°C. (32°F to 77°F) |
| Accuracy | Blood Temp ± 0.05°C; Inj. Temp ± 0.2 °C | Blood Temp ± 0.05°C; Inj. Temp ± 0.2 °C |
| Linearity | Better than 1% of full scale | Better than 1% of full scale |
| Temperature | ||
| Range | 27 °C to 45°C | 27 °C to 45°C |
| Accuracy | ± 0.2°C | ± 0.2°C |
| Respiration | ||
| Frequency Response | 0.13 to 2.5 Hz., 3 dB bandwidth | 0.13 to 2.5 Hz., 3 dB bandwidth |
| Range | 8 to 150 bpm | 8 to 150 bpm |
| Excitation | 65 kHz | 65 kHz |
| Pulse Oximetry (SpO2) | ||
| Probe Type | Masimo™ reusable or disposable | Masimo™ reusable or disposable |
| Range | 0% to 100% | 0% to 100% |
| Pulse Rate Range | 20-250 bpm, below 20 displays zero | 20-250 bpm, below 20 displays zero |
| Rate Accuracy | ± 3 bpm | ± 3 bpm |
| SpO2 Accuracy (Adult) | ±2 digits between 70% and 100%; ±3 digits between 50% and 70% | ±2 digits between 70% and 100%; ±3 digits between 50% and 70% |
| SpO2 Accuracy (Neonatal) | ±3 digits between 70% and 95% | ±3 digits between 70% and 95% |
| Auxiliary Inputs | ||
| Input Voltage | +/-5 Volt | +/-5 Volt |
| Frequency Response | DC to 120 Hz | DC to 120 Hz |
| Non-Invasive Blood Pressure (NIBP) | ||
| Method | Oscillometric | Oscillometric |
| Initial Inflation | 150 mmHg (adult); 120 mmHg (pediatric) | 150 mmHg (adult); 120 mmHg (pediatric) |
| Pressure Accuracy | Overall ± 3 mmHg, full scale | Overall ± 3 mmHg, full scale |
| Defib. Pulse Protection | 5KV as per ANSI/AAMI EC13 (9), clause 3.2.2.2 and per IEC 60601-2-27 (12), clauses 17, 101 and 102 | 5KV as per ANSI/AAMI EC13 (9), clause 3.2.2.2 and per IEC 60601-2-27 (12), clauses 17, 101 and 102 |
| Degree of protection against electrical shock | Type CF and BF (ECG, IBP and CO = CF; NIBP and SpO2 = BF) | Type CF and BF (ECG, IBP and CO = CF; NIBP and SpO2 = BF) |
| Electrosurgical Interference Suppression | Yes | Yes |
2. Sample size used for the test set and the data provenance
The document does not specify a separate "test set" in the context of image-based AI or diagnostic algorithm evaluation. Instead, it states that "The Cathlab with the CFE has been subject to extensive safety and performance testing to ensure that the signals/waveforms sent by the CFE to the Cathlab have the same characteristics as those sent by the PFE to the Cathlab." This implies a comparative testing approach rather than a traditional test set for an algorithm.
The data provenance is not explicitly detailed. It can be inferred that the testing was performed by "Mennen Medical Ltd." (Israel) and an "independent testing laboratory" for electrical safety and EMC. There's no mention of country of origin of data in terms of patient population or images, as this is a physiological monitoring device rather than an imaging or diagnostic device. The testing describes the performance characteristics of the hardware and software, not historical patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This device is a physiological monitor, not an AI or imaging diagnostic device that would require expert-established ground truth for a test set. The "ground truth" here is adherence to technical specifications and industry standards.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set
Not applicable, as there is no specific "test set" for diagnostic accuracy with human-expert adjudication in this context. The adjudication method for meeting technical standards would typically involve verification by qualified engineers/testers against established metrics.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This document pertains to a hardware modification for a physiological monitoring device and does not involve AI for interpretation or improvement of human reader performance.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a physiological monitor; its performance is described in terms of its ability to acquire and display patient data, not as a standalone diagnostic algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The "ground truth" used for this device modification is based on technical specifications, industry standards (e.g., ANSI/AAMI, IEC), and the performance characteristics of the predicate device (Horizon 9000WS Cathlab with PFE). The goal was to ensure the modified CFE matched or exceeded the performance of the existing PFE.
8. The sample size for the training set
Not applicable. This document describes a hardware device modification, not a machine learning model that would require a training set.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for a machine learning model described.
Ask a specific question about this device
Page 1 of 1